Global Hereditary Cancer Testing Market Size, Status and Forecast 2020-2026


Hereditary Cancer Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
    Ambry Genetics (Konica Minota)
    Asper Biogene
    Natera
    Caris Life Sciences
    BioReference Laboratories (GeneDx)
    LabSolutions
    Progenityi 1/4 ?Inc
    ARUP Laboratories
    NeoGenomics
    Blueprint Genetics
    CellMax Life
    Fulgent Genetics
    Myriad Genetics
    Myogenes
    LabCorp
    Quest Diagnostics
    Pathway Genomics
    Strand Life Sciences

Market segment by Type, the product can be split into
    RNA Testing
    DNA Testing
Market segment by Application, split into
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Other Cancers

Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
    1.4 Market by Type
        1.4.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2020 VS 2026
        1.4.2 RNA Testing
        1.4.3 DNA Testing
    1.5 Market by Application
        1.5.1 Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026
        1.5.2 Breast Cancer
        1.5.3 Gastrointestinal Cancer
        1.5.4 Prostate Cancer
        1.5.5 Respiratory/Lung Cancer
        1.5.6 Other Cancers
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Global Hereditary Cancer Testing Market Perspective (2015-2026)
    2.2 Global Hereditary Cancer Testing Growth Trends by Regions
        2.2.1 Hereditary Cancer Testing Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 Hereditary Cancer Testing Historic Market Share by Regions (2015-2020)
        2.2.3 Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026)
    2.3 Industry Trends and Growth Strategy
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Challenges
        2.3.4 Portera??s Five Forces Analysis
        2.3.5 Hereditary Cancer Testing Market Growth Strategy
        2.3.6 Primary Interviews with Key Hereditary Cancer Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
    3.1 Global Top Hereditary Cancer Testing Players by Market Size
        3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2015-2020)
        3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2015-2020)
        3.1.3 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.2 Global Hereditary Cancer Testing Market Concentration Ratio
        3.2.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
        3.2.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2019
    3.3 Hereditary Cancer Testing Key Players Head office and Area Served
    3.4 Key Players Hereditary Cancer Testing Product Solution and Service
    3.5 Date of Enter into Hereditary Cancer Testing Market
    3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2015-2020)
    4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
    5.1 Global Hereditary Cancer Testing Market Size by Application (2015-2020)
    5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2021-2026)

6 North America
    6.1 North America Hereditary Cancer Testing Market Size (2015-2020)
    6.2 Hereditary Cancer Testing Key Players in North America (2019-2020)
    6.3 North America Hereditary Cancer Testing Market Size by Type (2015-2020)
    6.4 North America Hereditary Cancer Testing Market Size by Application (2015-2020)

7 Europe
    7.1 Europe Hereditary Cancer Testing Market Size (2015-2020)
    7.2 Hereditary Cancer Testing Key Players in Europe (2019-2020)
    7.3 Europe Hereditary Cancer Testing Market Size by Type (2015-2020)
    7.4 Europe Hereditary Cancer Testing Market Size by Application (2015-2020)

8 China
    8.1 China Hereditary Cancer Testing Market Size (2015-2020)
    8.2 Hereditary Cancer Testing Key Players in China (2019-2020)
    8.3 China Hereditary Cancer Testing Market Size by Type (2015-2020)
    8.4 China Hereditary Cancer Testing Market Size by Application (2015-2020)

9 Japan
    9.1 Japan Hereditary Cancer Testing Market Size (2015-2020)
    9.2 Hereditary Cancer Testing Key Players in Japan (2019-2020)
    9.3 Japan Hereditary Cancer Testing Market Size by Type (2015-2020)
    9.4 Japan Hereditary Cancer Testing Market Size by Application (2015-2020)

10 Southeast Asia
    10.1 Southeast Asia Hereditary Cancer Testing Market Size (2015-2020)
    10.2 Hereditary Cancer Testing Key Players in Southeast Asia (2019-2020)
    10.3 Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020)
    10.4 Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020)

11 India
    11.1 India Hereditary Cancer Testing Market Size (2015-2020)
    11.2 Hereditary Cancer Testing Key Players in India (2019-2020)
    11.3 India Hereditary Cancer Testing Market Size by Type (2015-2020)
    11.4 India Hereditary Cancer Testing Market Size by Application (2015-2020)

12 Central & South America
    12.1 Central & South America Hereditary Cancer Testing Market Size (2015-2020)
    12.2 Hereditary Cancer Testing Key Players in Central & South America (2019-2020)
    12.3 Central & South America Hereditary Cancer Testing Market Size by Type (2015-2020)
    12.4 Central & South America Hereditary Cancer Testing Market Size by Application (2015-2020)

13 Key Players Profiles
    13.1 Ambry Genetics (Konica Minota)
        13.1.1 Ambry Genetics (Konica Minota) Company Details
        13.1.2 Ambry Genetics (Konica Minota) Business Overview
        13.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
        13.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020))
        13.1.5 Ambry Genetics (Konica Minota) Recent Development
    13.2 Asper Biogene
        13.2.1 Asper Biogene Company Details
        13.2.2 Asper Biogene Business Overview
        13.2.3 Asper Biogene Hereditary Cancer Testing Introduction
        13.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.2.5 Asper Biogene Recent Development
    13.3 Natera
        13.3.1 Natera Company Details
        13.3.2 Natera Business Overview
        13.3.3 Natera Hereditary Cancer Testing Introduction
        13.3.4 Natera Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.3.5 Natera Recent Development
    13.4 Caris Life Sciences
        13.4.1 Caris Life Sciences Company Details
        13.4.2 Caris Life Sciences Business Overview
        13.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
        13.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.4.5 Caris Life Sciences Recent Development
    13.5 BioReference Laboratories (GeneDx)
        13.5.1 BioReference Laboratories (GeneDx) Company Details
        13.5.2 BioReference Laboratories (GeneDx) Business Overview
        13.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
        13.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.5.5 BioReference Laboratories (GeneDx) Recent Development
    13.6 LabSolutions
        13.6.1 LabSolutions Company Details
        13.6.2 LabSolutions Business Overview
        13.6.3 LabSolutions Hereditary Cancer Testing Introduction
        13.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.6.5 LabSolutions Recent Development
    13.7 Progenityi 1/4 ?Inc
        13.7.1 Progenityi 1/4 ?Inc Company Details
        13.7.2 Progenityi 1/4 ?Inc Business Overview
        13.7.3 Progenityi 1/4 ?Inc Hereditary Cancer Testing Introduction
        13.7.4 Progenityi 1/4 ?Inc Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.7.5 Progenityi 1/4 ?Inc Recent Development
    13.8 ARUP Laboratories
        13.8.1 ARUP Laboratories Company Details
        13.8.2 ARUP Laboratories Business Overview
        13.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
        13.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.8.5 ARUP Laboratories Recent Development
    13.9 NeoGenomics
        13.9.1 NeoGenomics Company Details
        13.9.2 NeoGenomics Business Overview
        13.9.3 NeoGenomics Hereditary Cancer Testing Introduction
        13.9.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.9.5 NeoGenomics Recent Development
    13.10 Blueprint Genetics
        13.10.1 Blueprint Genetics Company Details
        13.10.2 Blueprint Genetics Business Overview
        13.10.3 Blueprint Genetics Hereditary Cancer Testing Introduction
        13.10.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
        13.10.5 Blueprint Genetics Recent Development
    13.11 CellMax Life
        10.11.1 CellMax Life Company Details
        10.11.2 CellMax Life Business Overview
        10.11.3 CellMax Life Hereditary Cancer Testing Introduction
        10.11.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020)
        10.11.5 CellMax Life Recent Development
    13.12 Fulgent Genetics
        10.12.1 Fulgent Genetics Company Details
        10.12.2 Fulgent Genetics Business Overview
        10.12.3 Fulgent Genetics Hereditary Cancer Testing Introduction
        10.12.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
        10.12.5 Fulgent Genetics Recent Development
    13.13 Myriad Genetics
        10.13.1 Myriad Genetics Company Details
        10.13.2 Myriad Genetics Business Overview
        10.13.3 Myriad Genetics Hereditary Cancer Testing Introduction
        10.13.4 Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
        10.13.5 Myriad Genetics Recent Development
    13.14 Myogenes
        10.14.1 Myogenes Company Details
        10.14.2 Myogenes Business Overview
        10.14.3 Myogenes Hereditary Cancer Testing Introduction
        10.14.4 Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020)
        10.14.5 Myogenes Recent Development
    13.15 LabCorp
        10.15.1 LabCorp Company Details
        10.15.2 LabCorp Business Overview
        10.15.3 LabCorp Hereditary Cancer Testing Introduction
        10.15.4 LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020)
        10.15.5 LabCorp Recent Development
    13.16 Quest Diagnostics
        10.16.1 Quest Diagnostics Company Details
        10.16.2 Quest Diagnostics Business Overview
        10.16.3 Quest Diagnostics Hereditary Cancer Testing Introduction
        10.16.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020)
        10.16.5 Quest Diagnostics Recent Development
    13.17 Pathway Genomics
        10.17.1 Pathway Genomics Company Details
        10.17.2 Pathway Genomics Business Overview
        10.17.3 Pathway Genomics Hereditary Cancer Testing Introduction
        10.17.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020)
        10.17.5 Pathway Genomics Recent Development
    13.18 Strand Life Sciences
        10.18.1 Strand Life Sciences Company Details
        10.18.2 Strand Life Sciences Business Overview
        10.18.3 Strand Life Sciences Hereditary Cancer Testing Introduction
        10.18.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
        10.18.5 Strand Life Sciences Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Disclaimer
    15.3 Author Details

List of Tables Table 1. Hereditary Cancer Testing Key Market Segments Table 2. Key Players Covered: Ranking by Hereditary Cancer Testing Revenue Table 3. Ranking of Global Top Hereditary Cancer Testing Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of RNA Testing Table 6. Key Players of DNA Testing Table 7. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Hereditary Cancer Testing Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Hereditary Cancer Testing Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Hereditary Cancer Testing Market Share by Regions (2015-2020) Table 11. Global Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Hereditary Cancer Testing Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Hereditary Cancer Testing Market Growth Strategy Table 17. Main Points Interviewed from Key Hereditary Cancer Testing Players Table 18. Global Hereditary Cancer Testing Revenue by Players (2015-2020) (Million US$) Table 19. Global Hereditary Cancer Testing Market Share by Players (2015-2020) Table 20. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019) Table 21. Global Hereditary Cancer Testing by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Hereditary Cancer Testing Product Solution and Service Table 24. Date of Enter into Hereditary Cancer Testing Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$) Table 27. Global Hereditary Cancer Testing Market Size Share by Type (2015-2020) Table 28. Global Hereditary Cancer Testing Revenue Market Share by Type (2021-2026) Table 29. Global Hereditary Cancer Testing Market Size Share by Application (2015-2020) Table 30. Global Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$) Table 31. Global Hereditary Cancer Testing Market Size Share by Application (2021-2026) Table 32. North America Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$) Table 33. North America Key Players Hereditary Cancer Testing Market Share (2019-2020) Table 34. North America Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$) Table 35. North America Hereditary Cancer Testing Market Share by Type (2015-2020) Table 36. North America Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$) Table 37. North America Hereditary Cancer Testing Market Share by Application (2015-2020) Table 38. Europe Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Hereditary Cancer Testing Market Share (2019-2020) Table 40. Europe Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$) Table 41. Europe Hereditary Cancer Testing Market Share by Type (2015-2020) Table 42. Europe Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$) Table 43. Europe Hereditary Cancer Testing Market Share by Application (2015-2020) Table 44. China Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$) Table 45. China Key Players Hereditary Cancer Testing Market Share (2019-2020) Table 46. China Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$) Table 47. China Hereditary Cancer Testing Market Share by Type (2015-2020) Table 48. China Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$) Table 49. China Hereditary Cancer Testing Market Share by Application (2015-2020) Table 50. Japan Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Hereditary Cancer Testing Market Share (2019-2020) Table 52. Japan Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$) Table 53. Japan Hereditary Cancer Testing Market Share by Type (2015-2020) Table 54. Japan Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$) Table 55. Japan Hereditary Cancer Testing Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Hereditary Cancer Testing Market Share (2019-2020) Table 58. Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Hereditary Cancer Testing Market Share by Type (2015-2020) Table 60. Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Hereditary Cancer Testing Market Share by Application (2015-2020) Table 62. India Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$) Table 63. India Key Players Hereditary Cancer Testing Market Share (2019-2020) Table 64. India Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$) Table 65. India Hereditary Cancer Testing Market Share by Type (2015-2020) Table 66. India Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$) Table 67. India Hereditary Cancer Testing Market Share by Application (2015-2020) Table 68. Central & South America Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Hereditary Cancer Testing Market Share (2019-2020) Table 70. Central & South America Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Hereditary Cancer Testing Market Share by Type (2015-2020) Table 72. Central & South America Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Hereditary Cancer Testing Market Share by Application (2015-2020) Table 74. Ambry Genetics (Konica Minota) Company Details Table 75. Ambry Genetics (Konica Minota) Business Overview Table 76. Ambry Genetics (Konica Minota) Product Table 77. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 78. Ambry Genetics (Konica Minota) Recent Development Table 79. Asper Biogene Company Details Table 80. Asper Biogene Business Overview Table 81. Asper Biogene Product Table 82. Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 83. Asper Biogene Recent Development Table 84. Natera Company Details Table 85. Natera Business Overview Table 86. Natera Product Table 87. Natera Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 88. Natera Recent Development Table 89. Caris Life Sciences Company Details Table 90. Caris Life Sciences Business Overview Table 91. Caris Life Sciences Product Table 92. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 93. Caris Life Sciences Recent Development Table 94. BioReference Laboratories (GeneDx) Company Details Table 95. BioReference Laboratories (GeneDx) Business Overview Table 96. BioReference Laboratories (GeneDx) Product Table 97. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 98. BioReference Laboratories (GeneDx) Recent Development Table 99. LabSolutions Company Details Table 100. LabSolutions Business Overview Table 101. LabSolutions Product Table 102. LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 103. LabSolutions Recent Development Table 104. Progenityi 1/4 ?Inc Company Details Table 105. Progenityi 1/4 ?Inc Business Overview Table 106. Progenityi 1/4 ?Inc Product Table 107. Progenityi 1/4 ?Inc Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 108. Progenityi 1/4 ?Inc Recent Development Table 109. ARUP Laboratories Business Overview Table 110. ARUP Laboratories Product Table 111. ARUP Laboratories Company Details Table 112. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 113. ARUP Laboratories Recent Development Table 114. NeoGenomics Company Details Table 115. NeoGenomics Business Overview Table 116. NeoGenomics Product Table 117. NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 118. NeoGenomics Recent Development Table 119. Blueprint Genetics Company Details Table 120. Blueprint Genetics Business Overview Table 121. Blueprint Genetics Product Table 122. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 123. Blueprint Genetics Recent Development Table 124. CellMax Life Company Details Table 125. CellMax Life Business Overview Table 126. CellMax Life Product Table 127. CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 128. CellMax Life Recent Development Table 129. Fulgent Genetics Company Details Table 130. Fulgent Genetics Business Overview Table 131. Fulgent Genetics Product Table 132. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 133. Fulgent Genetics Recent Development Table 134. Myriad Genetics Company Details Table 135. Myriad Genetics Business Overview Table 136. Myriad Genetics Product Table 137. Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 138. Myriad Genetics Recent Development Table 139. Myogenes Company Details Table 140. Myogenes Business Overview Table 141. Myogenes Product Table 142. Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 143. Myogenes Recent Development Table 144. LabCorp Company Details Table 145. LabCorp Business Overview Table 146. LabCorp Product Table 147. LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 148. LabCorp Recent Development Table 149. Quest Diagnostics Company Details Table 150. Quest Diagnostics Business Overview Table 151. Quest Diagnostics Product Table 152. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 153. Quest Diagnostics Recent Development Table 154. Pathway Genomics Company Details Table 155. Pathway Genomics Business Overview Table 156. Pathway Genomics Product Table 157. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 158. Pathway Genomics Recent Development Table 159. Strand Life Sciences Company Details Table 160. Strand Life Sciences Business Overview Table 161. Strand Life Sciences Product Table 162. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$) Table 163. Strand Life Sciences Recent Development Table 164. Research Programs/Design for This Report Table 165. Key Data Information from Secondary Sources Table 166. Key Data Information from Primary Sources List of Figures Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2020 VS 2026 Figure 2. RNA Testing Features Figure 3. DNA Testing Features Figure 4. Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026 Figure 5. Breast Cancer Case Studies Figure 6. Gastrointestinal Cancer Case Studies Figure 7. Prostate Cancer Case Studies Figure 8. Respiratory/Lung Cancer Case Studies Figure 9. Other Cancers Case Studies Figure 10. Hereditary Cancer Testing Report Years Considered Figure 11. Global Hereditary Cancer Testing Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Hereditary Cancer Testing Market Share by Regions: 2020 VS 2026 Figure 13. Global Hereditary Cancer Testing Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Hereditary Cancer Testing Market Share by Players in 2019 Figure 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2019 Figure 18. North America Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Bottom-up and Top-down Approaches for This Report Figure 26. Data Triangulation Figure 27. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Nut Harvester Market Insights and Forecast to 2026

Nut Harvester market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nut Harvester market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis ...

Global Fruit Harvester Market Insights and Forecast to 2026

Fruit Harvester market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Fruit Harvester market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analy...

Global Cleaner-Loader Market Insights and Forecast to 2026

Cleaner-Loader market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cleaner-Loader market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysi...

Global Sugar Beet Harvester Market Insights and Forecast to 2026

Sugar Beet Harvester market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sugar Beet Harvester market will be able to gain the upper hand as they use the report as a powerful resource. The segme...

Global Potato Digger Market Insights and Forecast to 2026

Potato Digger market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Potato Digger market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis ...

Publisher: QY Research
Chat with us